Xpovio (selinexor)

pCPA File Number: 21962

Negotiation Status:

Concluded with an LOI

Indication(s):

Multiple myeloma (MM) in adults with who have received at least one prior therapy (In combination with bortezomib (V) and dexamethasone (d))

Sponsor/Manufacturer:

Forus Therapeutics Inc.

CDA-AMC Project Number:

PC0276-000

pCPA Engagement Letter Issued:

2022-12-20

Negotiation Process Concluded:

2023-05-15